New hope for stomach cancer: adding surgery to drug therapy may improve outcomes

NCT ID NCT06468280

Recruiting now Disease control Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for people with stomach cancer that has spread to a few other places in the body. It tests whether adding surgery and other local treatments to a combination of immunotherapy and chemotherapy helps people live longer without the cancer getting worse. About 84 adults will take part and be randomly assigned to get either drug therapy alone or drug therapy plus surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric cancer gastric neoplasm gastroesophageal cancer gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER GASTROESOPHAGEAL CANCER

Contacts and locations

Locations

Zhongshan Hospital Fudan University
NOT_YET_RECRUITING

Shanghai, Shanghai City, 200032, China
Zhongshan Hospital, Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 201000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.